At WEP Clinical, our mission is to help patients get access to medicines. From our offices in the US, the UK, Ireland and Portugal we have a global reach, and we are committed to [...]

WEP Clinical, the specialist pharmaceutical services company, is proud to serve the rare disease community across the globe. As part of our overall mission to help patients get access to medicines and, ultimately, transform [...]

WEP Clinical (WEP), the specialist pharmaceutical services company, is excited to announce that, from the 1st November 2018, it will be operating out of a larger warehousing space, which will reside within the current [...]

WEP Clinical (WEP) is excited to announce that it is moving its US office location, due to a period of rapid growth and development for the company. Come September 18, 2017, the new WEP [...]

WEP Clinical, a global pharmaceutical and services company, and MendeliKABS Inc., a Canadian pharmaceutical company dedicated to the treatment of rare diseases, announce an exclusive Named Patient agreement to commercialise MDK-Nitisinone (nitisinone), a drug for [...]

As of 25 November 2016, our company name will officially change from: WE Pharma to WEP Clinical We believe that our new name more accurately reflects the services that we now provide. Our new [...]